SUPRANE

LOE Approaching

desflurane

NDAINHALATIONLIQUID
Approved
Sep 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
12

Mechanism of Action

Pharmacologic Class:

General Anesthetic

Clinical Trials (5)

NCT03917186Phase 4Completed

Desflurane vs. Sevoflurane in Endovascular Aortic Repair

Started Sep 2017
80 enrolled
Renal Failure
NCT02631525Phase 4Completed

Recovery Profile Comparison Between Remifentanil-propofol or Desflurane Anesthesia Monitored With Bispectral Index.

Started Aug 2014
40 enrolled
Delayed Emergence From Anesthesia
NCT01985854Phase 4Unknown

Conversion From Total Intravenous Anesthesia Technique to Desflurane Anesthesia for Long Duration Neurosurgery

Started Jan 2014
60 enrolled
Patients Undergoing Elective Craniotomy
NCT02019797Phase 4Unknown

Desflurane-induced Myocardial Protection

Started Jan 2014
50 enrolled
Aortic Valve Stenosis
NCT02324283N/AActive Not Recruiting

Comparison of Emergence and Oxygenation During One-lung Ventilation With Desflurane and Propofol Anesthesia

Started Oct 2012
80 enrolled
Lung Cancer
Data Sources
  • Drug label: DailyMed / FDA
  • Clinical trials: ClinicalTrials.gov
  • Patent data: FDA Orange Book
  • Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.